News & Updates

AI in Drug Discovery and Development: Emerging Technologies and Applications

09/03/2019

This year at DIA one of the overriding themes was with the value and benefit of Machine Learning and Artificial Intelligence. One of these sessions was of particular interest and a summary has since been published by DIA. “Assembling experts from the application and research side of drug discovery, the session AI in Drug Discovery…

Read More

Good Example of Integrating Wearable Devices (cameras) with Machine Learning Into Patient Care – The Potential For Use In Clinical Trials

08/31/2019

In a News Release on Eureka Alert, comes a fascinating example of how cameras were used in patient care combined with machine learning to better identify and improve lifestyle strategies for heart failure patients. The article titled “Tiny wearable cameras may improve quality of life in heart failure patients” and is an outstanding example of…

Read More

Meet with Christopher Kata, August 27th to 28th, 2019 in Philadelphia, PA!

08/18/2019

Meet with Christopher Kata, Director of Sales & Marketing on August 27th – 28th, 2019 in Philadelphia, PA! Christopher Kata, Director of Sales & Marketing905 999-1957ckata@trialstat.com When: August 27th to 28th 2019Where: Philadelphia, PA Christopher Kata is in Philadelphia for meetings both days and is available for additional meetings. If you’re interested in having a…

Read More

Meet with Christopher Kata in Tampa, Florida August 19th – 21st.

08/18/2019

Meet with Christopher Kata, Director of Sales & Marketing on August 19th – 21st, 2019 in Tampa, Florida! Christopher Kata, Director of Sales & Marketing905 999-1957ckata@trialstat.com When: August 19th to 21st 2019Where: Tampa, Florida Christopher Kata is in Tampa for meetings all three days and has some availability for additional meetings. If you’re interested in…

Read More

What Is Taking So Long For Meaningful Interoperability In Clinical Research?

08/16/2019

From Clinical Leader comes a very timely article on the state of interoperability within clinical research Clinical Trials today can benefit tremendously as a result of the value produced from integration with EMR systems, leveraging Real World Data and Real World Evidence, and the adoption of eSource! “Three decades ago when I entered the profession…

Read More

Meet with Christopher Kata at “DIA 2019” in Booth # 2633 on June 23rd – 27th in San Diego, CA

06/19/2019

Meet with Christopher Kata, Director of Sales & Marketing on June 23rd – 27th 2019 at “DIA 2019” Booth # 2633 in San Deigo CA! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: June 23rd – 27th 2019 Where: Booth # 2633 San Deigo Convention Center, 111 W Harbor Drive, San Deigo,…

Read More

WideTrial Partners With Oncotelic to Bring Expanded Access Platform to Cancer

06/14/2019

WideTrial , one of TrialStat’s strategic partners has partnered with Oncotelic to bring the Expanded Access Platform to Cancer. June 03, 2019 (ACCESSWIRE via COMTEX) — SAN FRANCISCO, CA / ACCESSWIRE / June 3, 2019 / WideTrial Inc., a third-party sponsor of Expanded Access programs, has begun a partnership with Oncotelic Inc., a wholly owned subsidiary…

Read More

FDA to Launch Expanded Access Pilot ‘Project Facilitate’

06/02/2019

The goal of Project Facilitate is to make it easier for oncologists or healthcare providers without the regulatory experience or resources to navigate the single patient IND process. “Access to clinical trials and access to novel therapeutics for patients is still a problem. We know that not all oncologists or healthcare providers have the regulatory…

Read More

Statement by FDA Commissioner Scott Gottlieb, M.D., Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D. and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D. on Expanded Access –Looking Forward

05/26/2019

In March of 2019 the FDA released this statement regarding the value of Expanded Access Programs and the FDA’s encouragement of Sponsors to consider providing them as options for Patient Populations. A few interesting statements worth highlighting in the statement: “Since 2010, drug sponsors and manufacturers have given the opportunity of such access to more…

Read More

Meet with Christopher Kata at the”6th Annual Clinical Operations in Oncology Trials West Coast” on April 30th & May 1st 2019

03/18/2019

Meet with Christopher Kata, Director of Sales & Marketing on April 30th & May 1st 2019 at the 6th Annual Clinical Operations in Oncology Trials! Christopher Kata, Director of Sales & Marketing905 999-1957ckata@trialstat.com When: April 30th & May 1st 2019 at 7:45 am – 5:00 pm Where: Burlingame, California Registration: http://www.arena-international.com/oncologywestcoast 6th Annual Clinical Operations in Oncology Trials…

Read More